Found: 41
Select item for more details and to access through your institution.
Comment on: "Regorafenib: Start Low and Go Slow".
- Published in:
- 2016
- By:
- Publication type:
- commentary
Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Sorafenib Plus Irinotecan Combination in Patients With RAS-mutated Metastatic Colorectal Cancer Refractory To Standard Combined Chemotherapies: A Multicenter, Randomized Phase 2 Trial (NEXIRI-2/PRODIGE 27).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Maintenance Therapy With Cetuximab After FOLFIRI Plus Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 9, p. e2333533, doi. 10.1001/jamanetworkopen.2023.33533
- By:
- Publication type:
- Article
DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00413-2
- By:
- Publication type:
- Article
Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal Cancers.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 8, p. 4427, doi. 10.3390/ijms23084427
- By:
- Publication type:
- Article
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 3, p. 442, doi. 10.1038/s41416-023-02524-3
- By:
- Publication type:
- Article
Role of FOLFIRINOX and chemoradiotherapy in locally advanced and borderline resectable pancreatic adenocarcinoma: update of the AGEO cohort.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
BRAF<sup>V600E</sup> Metastatic Colorectal Cancer: Perspective from a Patient, a Caregiver, and an Oncologist.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 8, p. 3281, doi. 10.1007/s12325-023-02552-8
- By:
- Publication type:
- Article
Outcomes of surgical resection in microsatellite instable colorectal cancer after immune checkpoint inhibitor treatment.
- Published in:
- British Journal of Surgery, 2023, v. 110, n. 9, p. 1043, doi. 10.1093/bjs/znac425
- By:
- Publication type:
- Article
Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network.
- Published in:
- European Journal of Endocrinology, 2014, v. 170, n. 4, p. 575, doi. 10.1530/EJE-13-0825
- By:
- Publication type:
- Article
Long‐Term Survivors in Metastatic Pancreatic Ductal Adenocarcinoma: A Retrospective and Matched Pair Analysis.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. 1543, doi. 10.1634/theoncologist.2018-0786
- By:
- Publication type:
- Article
Efficacy of Sunitinib in Advanced Medullary Thyroid Carcinoma: Intermediate Results of Phase II THYSU.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Improved guidance is needed to optimise diagnostics and treatment of patients with thyroid cancer in Europe.
- Published in:
- Endocrine (1355008X), 2024, v. 83, n. 3, p. 585, doi. 10.1007/s12020-023-03610-5
- By:
- Publication type:
- Article
Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study.
- Published in:
- World Journal of Surgical Oncology, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12957-022-02594-2
- By:
- Publication type:
- Article
Immunothérapie dans les tumeurs MSI non colorectales.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2023, v. 30, p. 17, doi. 10.1684/hpg.2023.2629
- By:
- Publication type:
- Article
Prise en charge de l'adénocarcinome pancréatique mé tastatique en 2017.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2017, v. 24, n. 8, p. 823, doi. 10.1684/hpg.2017.1503
- By:
- Publication type:
- Article
Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery.
- Published in:
- BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-200
- By:
- Publication type:
- Article
Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Results of combined treatment of anaplastic thyroid carcinoma (ATC).
- Published in:
- 2011
- By:
- Publication type:
- journal article
Phase II INTERACT-ION study: ezabenlimab (BI 754091) and mDCF (docetaxel, cisplatin, and 5-fluorouracil) followed by chemoradiotherapy in patients with Stage III squamous cell anal carcinoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.918499
- By:
- Publication type:
- Article
A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 T<sub>H</sub>1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL Study.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.957580
- By:
- Publication type:
- Article
Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network.
- Published in:
- Thyroid, 2023, v. 33, n. 10, p. 1190, doi. 10.1089/thy.2023.0164
- By:
- Publication type:
- Article
Sorafenib in Molecularly Selected Cancer Patients: Final Analysis of the MOST-Plus Sorafenib Cohort.
- Published in:
- Cancers, 2023, v. 15, n. 13, p. 3441, doi. 10.3390/cancers15133441
- By:
- Publication type:
- Article
Structural and Socio-Spatial Determinants Influencing Care and Survival of Patients with a Pancreatic Adenocarcinoma: Results of the PANDAURA Cohort.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5413, doi. 10.3390/cancers14215413
- By:
- Publication type:
- Article
Prognostic Value of Fusobacterium nucleatum after Abdominoperineal Resection for Anal Squamous Cell Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1606, doi. 10.3390/cancers14071606
- By:
- Publication type:
- Article
Treatments after Immune Checkpoint Inhibitors in Patients with dMMR/MSI Metastatic Colorectal Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 406, doi. 10.3390/cancers14020406
- By:
- Publication type:
- Article
Targeting HGF/c-Met Axis Decreases Circulating Regulatory T Cells Accumulation in Gastric Cancer Patients.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5562, doi. 10.3390/cancers13215562
- By:
- Publication type:
- Article
Management of Patients with Pancreatic Ductal Adenocarcinoma in the Real-Life Setting: Lessons from the French National Hospital Database.
- Published in:
- Cancers, 2021, v. 13, n. 14, p. 3515, doi. 10.3390/cancers13143515
- By:
- Publication type:
- Article
Clinical Relevance of Viable Circulating Tumor Cells in Patients with Metastatic Colorectal Cancer: The COLOSPOT Prospective Study.
- Published in:
- Cancers, 2021, v. 13, n. 12, p. 2966, doi. 10.3390/cancers13122966
- By:
- Publication type:
- Article
MRI-Based Radiomics Input for Prediction of 2-Year Disease Recurrence in Anal Squamous Cell Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 2, p. 193, doi. 10.3390/cancers13020193
- By:
- Publication type:
- Article
Stromal Protein-Mediated Immune Regulation in Digestive Cancers.
- Published in:
- Cancers, 2021, v. 13, n. 1, p. 146, doi. 10.3390/cancers13010146
- By:
- Publication type:
- Article
Association of COVID-19 Lockdown With the Tumor Burden in Patients With Newly Diagnosed Metastatic Colorectal Cancer.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 9, p. e2124483, doi. 10.1001/jamanetworkopen.2021.24483
- By:
- Publication type:
- Article
A Promising Biomarker and Therapeutic Target in Patients with Advanced PDAC: The Stromal Protein βig-h3.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 4, p. 623, doi. 10.3390/jpm12040623
- By:
- Publication type:
- Article
Effect of Buparlisib, a Pan-Class I PI3K Inhibitor, in Refractory Follicular and Poorly Differentiated Thyroid Cancer.
- Published in:
- Thyroid, 2018, v. 28, n. 9, p. 1174, doi. 10.1089/thy.2017.0663
- By:
- Publication type:
- Article
Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection.
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 3, p. 504, doi. 10.1002/ijc.34781
- By:
- Publication type:
- Article
Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2019, v. 104, n. 6, p. 2367, doi. 10.1210/jc.2018-01968
- By:
- Publication type:
- Article
Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The Activity of Crizotinib in Chemo-Refractory MET-Amplified Esophageal and Gastric Adenocarcinomas: Results from the AcSé-Crizotinib Program.
- Published in:
- 2021
- By:
- Publication type:
- journal article